
Deborah Crouch
Examiner (ID: 19500, Phone: (571)272-0727 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 3725, 1819, 1632, 2899, 1804 |
| Total Applications | 1439 |
| Issued Applications | 694 |
| Pending Applications | 237 |
| Abandoned Applications | 511 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 09/786039 | Mammary-specific transcription factor brets | Aug 16, 2001 | Abandoned |
Array
(
[id] => 1246380
[patent_doc_number] => 06677500
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-01-13
[patent_title] => 'Ungulates expressing exogenous IGF-I in their milk'
[patent_app_type] => B2
[patent_app_number] => 09/930377
[patent_app_country] => US
[patent_app_date] => 2001-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16796
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/677/06677500.pdf
[firstpage_image] =>[orig_patent_app_number] => 09930377
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/930377 | Ungulates expressing exogenous IGF-I in their milk | Aug 14, 2001 | Issued |
Array
(
[id] => 6541835
[patent_doc_number] => 20020110567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'In utero oral nucleic acid immunization'
[patent_app_type] => new
[patent_app_number] => 09/927408
[patent_app_country] => US
[patent_app_date] => 2001-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15118
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20020110567.pdf
[firstpage_image] =>[orig_patent_app_number] => 09927408
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/927408 | In utero oral nucleic acid immunization | Aug 9, 2001 | Abandoned |
Array
(
[id] => 6016922
[patent_doc_number] => 20020103152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Methods of in vivo gene transfer using a sleeping beauty transposon system'
[patent_app_type] => new
[patent_app_number] => 09/927886
[patent_app_country] => US
[patent_app_date] => 2001-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10368
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20020103152.pdf
[firstpage_image] =>[orig_patent_app_number] => 09927886
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/927886 | Methods of in vivo gene transfer using a sleeping beauty transposon system | Aug 9, 2001 | Issued |
Array
(
[id] => 6157420
[patent_doc_number] => 20020146678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Directed differentiation of embryonic cells'
[patent_app_type] => new
[patent_app_number] => 09/918702
[patent_app_country] => US
[patent_app_date] => 2001-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8215
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20020146678.pdf
[firstpage_image] =>[orig_patent_app_number] => 09918702
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/918702 | Directed differentiation of human embryonic cells | Jul 30, 2001 | Issued |
Array
(
[id] => 6035825
[patent_doc_number] => 20020019993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'Full term development of animals from enucleated oocytes reconstituted with adult somatic cell nuclei'
[patent_app_type] => new
[patent_app_number] => 09/919106
[patent_app_country] => US
[patent_app_date] => 2001-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15564
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019993.pdf
[firstpage_image] =>[orig_patent_app_number] => 09919106
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/919106 | Full term development of animals from enucleated oocytes reconstituted with adult somatic cell nuclei | Jul 30, 2001 | Abandoned |
Array
(
[id] => 6581409
[patent_doc_number] => 20020166129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Milk and milk products for preventing or treating heart disease'
[patent_app_type] => new
[patent_app_number] => 09/906807
[patent_app_country] => US
[patent_app_date] => 2001-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8914
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20020166129.pdf
[firstpage_image] =>[orig_patent_app_number] => 09906807
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/906807 | Milk lacking -casein A1 | Jul 17, 2001 | Issued |
Array
(
[id] => 5953107
[patent_doc_number] => 20020007497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-17
[patent_title] => 'Food product and process'
[patent_app_type] => new
[patent_app_number] => 09/906614
[patent_app_country] => US
[patent_app_date] => 2001-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6218
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0007/20020007497.pdf
[firstpage_image] =>[orig_patent_app_number] => 09906614
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/906614 | Food product and process | Jul 17, 2001 | Abandoned |
Array
(
[id] => 773294
[patent_doc_number] => 07001769
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-02-21
[patent_title] => 'Nucleic acid sequences and proteins involved in cellular senescence'
[patent_app_type] => utility
[patent_app_number] => 10/363924
[patent_app_country] => US
[patent_app_date] => 2001-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 20
[patent_no_of_words] => 10948
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/001/07001769.pdf
[firstpage_image] =>[orig_patent_app_number] => 10363924
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/363924 | Nucleic acid sequences and proteins involved in cellular senescence | Jul 5, 2001 | Issued |
| 09/880711 | Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby | Jun 11, 2001 | Abandoned |
Array
(
[id] => 1151801
[patent_doc_number] => 06770797
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-08-03
[patent_title] => 'Non-Transgenic nonhuman model for Alzheimer\'s Disease using a AD7c-NTP nucleic acid'
[patent_app_type] => B2
[patent_app_number] => 09/872968
[patent_app_country] => US
[patent_app_date] => 2001-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 68
[patent_no_of_words] => 17991
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/770/06770797.pdf
[firstpage_image] =>[orig_patent_app_number] => 09872968
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/872968 | Non-Transgenic nonhuman model for Alzheimer's Disease using a AD7c-NTP nucleic acid | May 31, 2001 | Issued |
Array
(
[id] => 432485
[patent_doc_number] => 07265259
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-04
[patent_title] => 'GSK-3β expressed in a transgenic mouse'
[patent_app_type] => utility
[patent_app_number] => 10/276460
[patent_app_country] => US
[patent_app_date] => 2001-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10998
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/265/07265259.pdf
[firstpage_image] =>[orig_patent_app_number] => 10276460
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/276460 | GSK-3β expressed in a transgenic mouse | May 17, 2001 | Issued |
Array
(
[id] => 6896777
[patent_doc_number] => 20010027567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-04
[patent_title] => 'Production of somatic mosaicism in mammals using a recombinatorial substrate'
[patent_app_type] => new
[patent_app_number] => 09/854869
[patent_app_country] => US
[patent_app_date] => 2001-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11332
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20010027567.pdf
[firstpage_image] =>[orig_patent_app_number] => 09854869
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/854869 | Production of somatic mosaicism in mammals using a recombinatorial substrate | May 13, 2001 | Abandoned |
Array
(
[id] => 5938039
[patent_doc_number] => 20020062492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Transgenic animals expressing human coagulation factor VIII and von willebrand factor'
[patent_app_type] => new
[patent_app_number] => 09/849406
[patent_app_country] => US
[patent_app_date] => 2001-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6047
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20020062492.pdf
[firstpage_image] =>[orig_patent_app_number] => 09849406
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/849406 | Transgenic non-human mammals expressing human coagulation factor VIII and von Willebrand factor | May 6, 2001 | Issued |
Array
(
[id] => 6885502
[patent_doc_number] => 20010039667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-08
[patent_title] => 'Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson\'s disease'
[patent_app_type] => new
[patent_app_number] => 09/845352
[patent_app_country] => US
[patent_app_date] => 2001-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 28523
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20010039667.pdf
[firstpage_image] =>[orig_patent_app_number] => 09845352
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/845352 | Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease | Apr 30, 2001 | Abandoned |
Array
(
[id] => 6349416
[patent_doc_number] => 20020035737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'Cloning pigs using donor nuclei from differentiated cells'
[patent_app_type] => new
[patent_app_number] => 09/845353
[patent_app_country] => US
[patent_app_date] => 2001-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10563
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20020035737.pdf
[firstpage_image] =>[orig_patent_app_number] => 09845353
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/845353 | Cloning pigs using donor nuclei from differentiated cells | Apr 30, 2001 | Abandoned |
Array
(
[id] => 6032737
[patent_doc_number] => 20020018988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'In silico screening'
[patent_app_type] => new
[patent_app_number] => 09/843135
[patent_app_country] => US
[patent_app_date] => 2001-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5810
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20020018988.pdf
[firstpage_image] =>[orig_patent_app_number] => 09843135
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/843135 | In silico screening | Apr 25, 2001 | Abandoned |
Array
(
[id] => 6894585
[patent_doc_number] => 20010016951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-23
[patent_title] => 'Transgenic animal model for alzheimer disease'
[patent_app_type] => new
[patent_app_number] => 09/841971
[patent_app_country] => US
[patent_app_date] => 2001-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2742
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20010016951.pdf
[firstpage_image] =>[orig_patent_app_number] => 09841971
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/841971 | Transgenic animal model for alzheimer disease | Apr 24, 2001 | Abandoned |
Array
(
[id] => 5877238
[patent_doc_number] => 20020049988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Transgenic animals harboring APP allele having swedish mutation'
[patent_app_type] => new
[patent_app_number] => 09/838556
[patent_app_country] => US
[patent_app_date] => 2001-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15711
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20020049988.pdf
[firstpage_image] =>[orig_patent_app_number] => 09838556
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/838556 | Transgenic rodents harboring APP allele having Swedish mutation | Apr 17, 2001 | Issued |
Array
(
[id] => 6278569
[patent_doc_number] => 20020107213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Gene therapy of alzheimer\'s disease by delivery of an encoded apoliprotein E'
[patent_app_type] => new
[patent_app_number] => 09/835647
[patent_app_country] => US
[patent_app_date] => 2001-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5645
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20020107213.pdf
[firstpage_image] =>[orig_patent_app_number] => 09835647
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/835647 | Gene therapy of alzheimer's disease by delivery of an encoded apoliprotein E | Apr 15, 2001 | Abandoned |